[Prognostic factors in primary radiochemo-therapy in advanced head and neck tumours with specific reference to the tumour cell cycle components and tumour oxygenation].
Dietz
A
A
HNO-Universitäts-Klinik Heidelberg, Germany. http://www.hyg.uni-heidelberg.de/hno/consilium/con-vst.htm.
D014408:Biomarkers, Tumor / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D002453:Cell Cycle / Q000528:radiation effects*; D015687:Cell Hypoxia / Q000528:radiation effects*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D009367:Neoplasm Staging; D010039:Otorhinolaryngologic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D011379:Prognosis
D014408:Biomarkers, Tumor